Results 71 to 80 of about 20,074 (213)
Quality indicators in respiratory therapy
Quality indicators in healthcare refer to measurable and quantifiable parameters used to assess and monitor the performance, effectiveness, and safety of healthcare services. These indicators provide a systematic way to evaluate the quality of care offered, and thereby to identify areas for improvement and to ensure that patient care meets established ...
Karthika, Manjush +2 more
openaire +2 more sources
Helmet Ventilation in a Child with COVID-19 and Acute Respiratory Distress Syndrome
Background. In pediatric patients with severe COVID-19, if the respiratory support provided using high-flow nasal cannula (HFNC) becomes insufficient, no definitive evidence exists to support the escalation to noninvasive ventilation (NIV) or mechanical ...
Ke-Yun Chao +4 more
doaj +1 more source
Introduction: The access and compliance of patients with interstitial lung diseases (ILDs) to exercise programs (EPs) remain challenges. Objectives: We assessed the dropout rate, intervention completion, compliance with data acquisition and submission ...
Antonio Sarmento +2 more
doaj +1 more source
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao +5 more
wiley +1 more source
Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach +23 more
wiley +1 more source
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
Shahd Ali Alshamrani,1– 3 Sara Abdullah Alrogaib,1– 3 Rema Mohammed Alharthi,1– 3 Norah Abdullah Alharthi,1– 3 Muhammad Anwar Khan,2– 4 Raju Suresh Kumar5 1Department of Respiratory Therapy, College of Applied Medical Sciences, King Saud bin Abdulaziz ...
Alshamrani SA +5 more
doaj
Nicotine pouches: a narrative review of the existing literature
IntroductionNicotine pouches are an emerging a non-combustible nicotine product. These tobacco-free oral products deliver nicotine through the gums.
Hajed M. Al-Otaibi +3 more
doaj +1 more source
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi +5 more
wiley +1 more source
Abdulelah M Aldhahir,1,2 Mohammed M Alyami,3 Osama Alanazi,3 Ahmed H Alasimi,4 Abdullah A Alqarni,5,6 Jaber S Alqahtani,7 Abdallah Y Naser,8 Hassan Alwafi,9 Mohammad S Dairi,10 Saeed M Alghamdi,11 Rayan A Siraj,12 Nowaf Y Alobaidi,13,14 Mohammed A ...
Aldhahir AM +13 more
doaj

